APA (7th ed.) Citation

J, N., MN, M., B, W., S, D., J, R., MR, M., . . . DE, N. (2024). PAR4 Antagonism in Patients With Coronary Artery Disease Receiving Antiplatelet Therapies. Arteriosclerosis, thrombosis, and vascular biology, 44(4), 987. https://doi.org/10.1161/ATVBAHA.123.320448

Chicago Style (17th ed.) Citation

J, Nash, et al. "PAR4 Antagonism in Patients With Coronary Artery Disease Receiving Antiplatelet Therapies." Arteriosclerosis, Thrombosis, and Vascular Biology 44, no. 4 (2024): 987. https://doi.org/10.1161/ATVBAHA.123.320448.

MLA (9th ed.) Citation

J, Nash, et al. "PAR4 Antagonism in Patients With Coronary Artery Disease Receiving Antiplatelet Therapies." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 44, no. 4, 2024, p. 987, https://doi.org/10.1161/ATVBAHA.123.320448.